Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy | Canada Hyperbarics Skip to main content
Case Report Pediatr Hematol Oncol 2013

Successful treatment of rhino-orbital mucormycosis with posaconazole and hyperbaric oxygen therapy

Almannai M, Imran H, Estrada B, Siddiqui A — Pediatr Hematol Oncol, 2013

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a toddler with acute lymphoblastic leukemia who developed rhino-orbital mucormycosis caused by Rhizopus species.

What They Found

The patient was successfully treated with multiple surgical debridements, amphotericin B, posaconazole, and hyperbaric oxygen therapy. This combined approach, which included posaconazole and hyperbaric oxygen therapy, was found to be safe and effective in this specific case.

What This Means for Canadian Patients

This case report suggests a potential multimodal treatment strategy for a rare and aggressive fungal infection in immunocompromised patients. The combination of surgery, antifungal medications, and hyperbaric oxygen therapy may offer a viable option for Canadian patients facing similar challenging infections.

Canadian Relevance

This study has no direct Canadian connection as it is a case report from an unspecified location outside of Canada.

Study Limitations

As a single case report, the findings cannot be generalized to a larger patient population.

Was this summary helpful?

Study Details

Study Type Case Report
Category Infection
Source Pubmed
PubMed ID 23444832
Year Published 2013
Journal Pediatr Hematol Oncol
MeSH Terms Adult; Amphotericin B; Antifungal Agents; Child, Preschool; Combined Modality Therapy; Female; Humans; Hyperbaric Oxygenation; Mucormycosis; Orbital Diseases; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Rhizopus; Tomography, X-Ray Computed; Triazoles

Cite This Study

Share

Find a Canadian Clinic

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.